Fulvestrant Efficacy in Artificial Menopausal Hormone Receptor Positive and Human Epidermal Growth Factor Receptor 2 Negative Metastatic Breast Cancer Patients under 50 Years Old

Journal Title: International Journal of Current Research and Review - Year 2018, Vol 10, Issue 6

Abstract

Introduction: This study investigated the efficacy of fulvestrant in premenopausal patients with metastatic breast cancer who developed artificial menopause using a luteinizing hormone releasing hormone analogue. Methods: This retrospective study was conducted at the Istanbul Okmeydani Education and Research Hospital. Results: A total of 37 patients were evaluated, with a median age of 39 years old (range 27–49) and a median follow-up time of 20.2 months (0–78). Of these patients, 86.5% had invasive ductal carcinoma, 5.4% had invasive lobular carcinoma. Bone metastasis was found in 83.8% of the patients, lung metastasis in 21.6%, lymph node metastasis in 16.2%, liver metastasis in 13.5%, and brain metastasis in 5.4%. The progression-free survival (PFS) was a median of 12 months after starting the fulvestrant. The PFS was relatively shorter in those with brain metastases, but there was no statistically significant difference. The median PFS was 12 months in 2 series and 8 months in 3 and later series, which was statistically significant (p=0.025). The overall survival (OS) was a median of 77 months; it was 86% at 12 months, 63% at 36 months, and 56% at 60 months. The median OS of the 2nd line was 20 months. No grade 3-4 toxic effects were observed. Conclusion: As in naturally postmenopausal patients, fulvestrant was found to be effective and tolerable in patients treated with artificial menopausal hormone receptor-positive metastatic breast cancer under the age of 50. The fulvestrant was more effective in those who did not previously receive hormonal therapy.

Authors and Affiliations

Caglayan Geredeli

Keywords

Related Articles

Tinea Capitis Among Primary School Children: A Clinicomycological Study in a Rural Hospital in Central India

Aims & Objectives 1. To determine the clinical & mycological profile of tinea capitis Among Primary School students of Rural area 2. To correlate of KOH microscopy and culture for diagnosing Tinea capitis. Methods & Resu...

Investigation of the Efficiency of Endotracheal Aspiration by Sheep Lung Modeling: Experimental Study

Background: The clinical and radiological evaluation of endotracheal suctioning (ETS), which is performed as a blind procedure has incapacities. The purpose of this study was to indicate that angulation of the ETT tube t...

Promoting Rural Entrepreneurship Through Skill Development for Decent Livelihood: A Review

Unemployment, especially among rural people is a biggest challenge for India. As a result rural people are moving towards urban areas to obtain better employment opportunities and amenities of life. Agriculture is the pr...

Prevalence of asymptomatic malaria parasitaemia during pregnancy and its effect on foetal birth weight

Background: Pregnant women in endemic area may experience malaria infection without clinical symptoms. Its effects on the neonatal outcomes mayalso occur in this asymptomatic state. Objective: To determine the prevalence...

Emergency Obstetric Hysterectomy, Risk Factors, Indications and Outcome: A Retrospective Two Year Study

Background: Obstetric emergency hysterectomy means that emergency hysterectomy which is taken after drug therapy and conservative surgery fails to control blood loss from gravid uterus. It is the last resort to save moth...

Download PDF file
  • EP ID EP542237
  • DOI 10.7324/IJCRR.2018.1067
  • Views 125
  • Downloads 0

How To Cite

Caglayan Geredeli (2018). Fulvestrant Efficacy in Artificial Menopausal Hormone Receptor Positive and Human Epidermal Growth Factor Receptor 2 Negative Metastatic Breast Cancer Patients under 50 Years Old. International Journal of Current Research and Review, 10(6), 31-36. https://europub.co.uk/articles/-A-542237